Despite impressive HRs, however, most of these differences did not reach statistical significance (Table 2 ).
← all excerpts
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma.
1
—
—